The use of IL-8 antagonists (such as the fully humanized neutralizing monoclonal antibody ABX-IL8) to IL-8 was shown to reduce tumor growth, metastasis, and angiogenesis of melanoma [209] and lung cancer [75]. Here, CXCL8 is linked to neoplasm.